BIVIbenzinga

BioVie Announces It Will Present Rationale And Design of Phase 2 SUNRISE-PD Clinical Trial At 30th World Congress On Parkinson's Disease And Related Disorders May 7-10, 2025 In New York City

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 7, 2025 by benzinga